This article explores evolving pharmaceutical regulatory compliance and GMP requirements shaping global manufacturing. It explains FDA and EMA inspection expectations, data integrity standards, and quality risk management frameworks that define how pharmaceutical companies maintain inspection readiness and regulatory alignment.
